BULLISHWHALES
BullishWhales · Congress · Trade Detail
--allergan plc Ordinary shares (agN) F IlINg s TaTus : New
RepublicanHouse

Ed Whitfield bought allergan plc Ordinary shares (agN) F IlINg s TaTus : New (--)

Ed Whitfield (R-KY), a U.S. Representative, has disclosed 64 trades in allergan plc Ordinary shares (agN) F IlINg s TaTus : New (--) since 2012, 41 purchases and 23 sales, worth an estimated $1.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Ed Whitfield bought $1,001 - $15,000 of allergan plc Ordinary shares (agN) F IlINg s TaTus : New (--) on May 6, 2016. Since that trade, -- is up +0.00% against the S&P 500 up +330.11%, an outperformance of -330.11%.

Across these filings, Ed Whitfield has been a net buyer of -- (a buy-to-sell ratio of 1.78). The most recent disclosed -- transaction shown was dated May 19, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

-- trades
64
Disclosed Vol
$1.1M
Buys
41
64%
Sells
23
36%
Buy / Sell
1.78
ratio
First → Last
2012–2016

Ed Whitfield's -- trades vs the price

-- is up +0.00% since Ed Whitfield bought on May 6, 2016, versus +330.11% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+330.11%
Outperformance vs S&P 500
-330.11%

All Ed Whitfield -- trades

TradedTypeSizeReturnEst. profit
May 19, 2016BUY$1,001 - $15,000N/A
May 6, 2016BUY$1,001 - $15,000N/A
May 4, 2016BUY$1,001 - $15,000N/A
March 11, 2016SELL$1,001 - $15,000N/A
February 22, 2016SELL$1,001 - $15,000N/A
February 22, 2016SELL$1,001 - $15,000N/A
February 22, 2016SELL$15,001 - $50,000N/A
February 9, 2016SELL$1,001 - $15,000N/A
February 9, 2016SELL$1,001 - $15,000N/A
February 8, 2016BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Ed Whitfield & -- trading FAQ

Is it legal for Ed Whitfield to trade allergan plc Ordinary shares (agN) F IlINg s TaTus : New (--) stock?

Yes. Members of Congress are allowed to trade individual stocks, including allergan plc Ordinary shares (agN) F IlINg s TaTus : New (--), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.

When did Ed Whitfield buy --?

Ed Whitfield disclosed a purchase of $1,001 - $15,000 of allergan plc Ordinary shares (agN) F IlINg s TaTus : New (--) on May 6, 2016, according to public STOCK Act filings.

How has -- performed since Ed Whitfield's trade?

Since Ed Whitfield bought -- on May 6, 2016, the stock is up +0.00%, versus +330.11% for the S&P 500 over the same period, an outperformance of -330.11%.

How many times has Ed Whitfield traded --?

Ed Whitfield has disclosed 64 -- trades since 2012 (41 purchases and 23 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional -- trades?

BullishWhales tracks every disclosed congressional trade in allergan plc Ordinary shares (agN) F IlINg s TaTus : New (--) on the allergan plc Ordinary shares (agN) F IlINg s TaTus : New congressional trading page, which aggregates filings across all members of Congress.

Ed Whitfield's -- tradesAll congressional filings for allergan plc Ordinary shares (agN) F IlINg s TaTus : NewEd Whitfield's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30